FORTIS HEALTHCARE LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 446.1 INR | +0.28% |
|
+3.80% | +6.52% |
| Mar. 14 | Fortis Healthcare Appoints Chief Internal Audit and Risk Officer | MT |
| Mar. 13 | Fortis Healthcare Limited Approves the Appointment of Sanjay Baweja as Chief Internal Audit and Risk Officer | CI |
| Sales 2024 * | 69.64B 836M | Sales 2025 * | 79.38B 953M | Capitalization | 336B 4.03B |
|---|---|---|---|---|---|
| Net income 2024 * | 6.06B 72.74M | Net income 2025 * | 8.15B 97.79M | EV / Sales 2024 * | 4.85 x |
| Net Debt 2024 * | 2.2B 26.35M | Net cash position 2025 * | 1.7B 20.38M | EV / Sales 2025 * | 4.21 x |
| P/E ratio 2024 * |
55.5
x | P/E ratio 2025 * |
40.8
x | Employees | 13,010 |
| Yield 2024 * |
0.23% | Yield 2025 * |
0.28% | Free-Float | 64.18% |
More Fundamentals
* Assessed data
More news
Latest transcript on Fortis Healthcare Limited
More recommendations
More press releases
| 1 day | +0.38% | ||
| 1 week | +3.80% | ||
| Current month | +6.27% | ||
| 1 month | +8.64% | ||
| 3 months | +5.28% | ||
| 6 months | +39.50% | ||
| Current year | +6.52% |
1 week
430.15
457.30
1 month
408.40457.30
Current year
375.05469.70
1 year
254.75469.70
3 years
205.30469.70
5 years
111.30469.70
10 years
97.25469.70
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 19-03-18 | |
Daljit Singh
PSD | President | 71 | 02-08-31 |
| Director of Finance/CFO | - | 19-04-07 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mehmet Aydinlar
BRD | Director/Board Member | 67 | 23-03-27 |
| Director/Board Member | 68 | 18-04-26 | |
Prem Kumar Nair
BRD | Director/Board Member | 64 | Nov. 09 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.25% | 6 M€ | +6.07% | - | |
| 0.03% | 4 M€ | -4.41% | - | |
| 0.02% | 117 M€ | +0.16% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 446.1 | +0.28% | 153 751 |
| 24-04-25 | 444.8 | -1.14% | 716,149 |
| 24-04-24 | 450 | +1.00% | 744,571 |
| 24-04-23 | 445.6 | +0.95% | 1,100,032 |
| 24-04-22 | 441.4 | +2.59% | 2,366,953 |
Delayed Quote NSE India S.E., April 26, 2024 at 03:10 am EDT
More quotes
Fortis Healthcare Limited is an India-based integrated healthcare delivery service provider. The Company is primarily engaged in the business of healthcare services. The Company operates through healthcare services segment. Its specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, pulmonology, urology, neurosurgery, radiology, orthopedics, and organ transplant, among others. It manages and operates a network of multi-specialty hospitals and diagnostics centers. The healthcare verticals of the Company primarily consist of hospitals, diagnostics, and day care specialty facilities. It has approximately 27 healthcare facilities, including projects under development, 4500 operational beds and over 400 diagnostics centers. It operates in India, United Arab Emirates and Sri Lanka. Its subsidiaries include Escorts Heart Institute and Research Centre Limited, Fortis Health staff Limited, and Fortis Asia Healthcare Pte. Ltd, among others.
Calendar
2024-05-22
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
444.8
INR
Average target price
482.2
INR
Spread / Average Target
+8.40%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +6.52% | 4.03B | |
| -22.63% | 15.76B | |
| +3.60% | 12.34B | |
| +3.65% | 11.52B | |
| +9.98% | 11.02B | |
| +24.00% | 8.28B | |
| -2.19% | 7.8B | |
| +20.75% | 7.2B | |
| +4.53% | 6.67B | |
| +49.97% | 4.64B |
- Stock Market
- Equities
- FORTIS Stock
